Health care costs related to home spirometry in the eICE randomized trial
- 12 March 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Cystic Fibrosis
- Vol. 21 (1), 61-69
- https://doi.org/10.1016/j.jcf.2021.02.014
Abstract
No abstract availableKeywords
Funding Information
- Cystic Fibrosis Foundation (P30 DK 089507, R01FD003704, R01FD006848, UL1TR000423, UM1HL119073)
- Cystic Fibrosis Foundation Therapeutics (KESSLE17AB0)
This publication has 19 references indexed in Scilit:
- Frequency and costs of pulmonary exacerbations in patients with cystic fibrosis in the United StatesCurrent Medical Research and Opinion, 2017
- Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: The early intervention in cystic fibrosis exacerbation (eICE) trialContemporary Clinical Trials, 2013
- Resource Use, Costs, and Utility Estimates for Patients with Cystic Fibrosis with Mild Impairment in Lung Function: Analysis of Data Collected Alongside a 48-Week Multicenter Clinical TrialValue in Health, 2012
- Comparison of 7-day and repeated 24-hour recall of symptoms of cystic fibrosisJournal of Cystic Fibrosis, 2010
- Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosisPediatric Pulmonology, 2010
- Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary ExacerbationAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Return of FEV1 after pulmonary exacerbation in children with cystic fibrosisPediatric Pulmonology, 2010
- Patient-reported respiratory symptoms in cystic fibrosisJournal of Cystic Fibrosis, 2009
- Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesisThorax, 2007
- Impact of Recent Pulmonary Exacerbations on Quality of Life in Patients With Cystic FibrosisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2002